The effect of cerebrolysin versus placebo on improvement of patients with acute ischemic stroke
Phase 2
- Conditions
- Ichemic stroke.cerebral infarction
- Registration Number
- IRCT201406169014N36
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
(a) having ischemic stroke; (b) age of 40 to 85 years; (c) referring the patient within less than 24 hours after stroke.
Exclusion criteria: (a) being in coma; (b) having systolic blood pressure above 240 mmHg or diastolic blood pressure above 120 mmHg; (c) history of myocardial infarction or heart failure; (d) history of renal failure; (e) history of liver failure; (f) having severe dementia.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring motor function. Timepoint: before intervention and 3 and 7 days after intervention. Method of measurement: using Canadian Stroke Scale.
- Secondary Outcome Measures
Name Time Method Measuring motor function. Timepoint: one month after intervention. Method of measurement: using Madified Ranking Scale.;Measuring motor function. Timepoint: one month after intervention. Method of measurement: using Bartel Index.